MX9603602A - Anticuerpo especifico para fibrina para su uso como agente antitrombotico. - Google Patents
Anticuerpo especifico para fibrina para su uso como agente antitrombotico.Info
- Publication number
- MX9603602A MX9603602A MX9603602A MX9603602A MX9603602A MX 9603602 A MX9603602 A MX 9603602A MX 9603602 A MX9603602 A MX 9603602A MX 9603602 A MX9603602 A MX 9603602A MX 9603602 A MX9603602 A MX 9603602A
- Authority
- MX
- Mexico
- Prior art keywords
- fibrin
- specific antibody
- antithrombotic agent
- methods
- kits
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invencion se refiere a métodos para el uso de un anticuerpo específico para fibrina para la inhibicion in vivo de la formacion de trombos. Se proporcionan también composiciones farmacéuticas así como Kits para su uso en tales métodos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/204,015 US5487892A (en) | 1994-02-24 | 1994-02-24 | Method for treating thrombotic disease using a fibrin specific monoclonal antibody |
PCT/US1995/001825 WO1995022986A1 (en) | 1994-02-24 | 1995-02-21 | Fibrin-specific antibody for use as an antithrombotic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9603602A true MX9603602A (es) | 1997-05-31 |
Family
ID=22756260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9603602A MX9603602A (es) | 1994-02-24 | 1995-02-21 | Anticuerpo especifico para fibrina para su uso como agente antitrombotico. |
Country Status (26)
Country | Link |
---|---|
US (1) | US5487892A (es) |
EP (1) | EP0749320A4 (es) |
JP (1) | JPH09509429A (es) |
KR (1) | KR970701063A (es) |
CN (1) | CN1146157A (es) |
AU (1) | AU708897B2 (es) |
BG (1) | BG62476B1 (es) |
BR (1) | BR9506949A (es) |
CA (1) | CA2183953A1 (es) |
CZ (1) | CZ246496A3 (es) |
FI (1) | FI963288A0 (es) |
GE (1) | GEP20002257B (es) |
HU (1) | HUT76536A (es) |
LT (1) | LT4192B (es) |
LV (1) | LV11784B (es) |
MD (1) | MD1521G2 (es) |
MX (1) | MX9603602A (es) |
NO (1) | NO963497L (es) |
NZ (1) | NZ281481A (es) |
PL (1) | PL316005A1 (es) |
RU (1) | RU2152801C2 (es) |
SG (1) | SG53279A1 (es) |
SK (1) | SK108496A3 (es) |
TJ (1) | TJ301B (es) |
UA (1) | UA41984C2 (es) |
WO (1) | WO1995022986A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5582862A (en) * | 1988-04-04 | 1996-12-10 | General Hospital Corporation | Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin |
US5453359A (en) * | 1988-06-13 | 1995-09-26 | American Biogenetic Sciences, Inc. | Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers |
US5817768A (en) * | 1995-06-07 | 1998-10-06 | The New York Blood Center, Inc. | Monospecific antibodies against a subunit of fibrinogen |
US6727102B1 (en) | 1997-06-20 | 2004-04-27 | Leuven Research & Development Vzw | Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins |
US6309888B1 (en) * | 1998-09-04 | 2001-10-30 | Leuven Research & Development Vzw | Detection and determination of the stages of coronary artery disease |
IL134828A0 (en) * | 2000-03-01 | 2001-05-20 | Eship 4U Com Inc | System for delivery and receipt of dispatches especially useful for e-commerce |
US20050181451A1 (en) * | 2004-02-12 | 2005-08-18 | Bates Harold M. | Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants |
ATE517991T1 (de) * | 2004-12-28 | 2011-08-15 | Sekisui Medical Co Ltd | Monoklonaler antikörper gegen menschliches lösliches fibrin sowie immunologisches testverfahren unter verwendung des antikörpers |
CN103501825B (zh) | 2011-05-02 | 2017-03-15 | 免疫医疗公司 | 用于小体积施用的同种异型选择的抗体的超滤浓缩 |
AU2013302696B9 (en) | 2012-08-14 | 2018-08-09 | Ibc Pharmaceuticals, Inc. | T-cell redirecting bispecific antibodies for treatment of disease |
CN118001422A (zh) | 2012-12-13 | 2024-05-10 | 免疫医疗公司 | 功效改进且毒性降低的抗体与sn-38的免疫缀合物的剂量 |
CN110563258A (zh) * | 2019-09-06 | 2019-12-13 | 广东石油化工学院 | 一种猪场废水厌氧产氢与达标排放处理方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU572125B2 (en) * | 1983-03-17 | 1988-05-05 | Mabco Limited | Monoclonal antibodies with specificity for crosslinked fibrin and their diagnotic uses |
US4722903A (en) * | 1983-11-14 | 1988-02-02 | New York Blood Center, Inc. | Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II |
US4916070A (en) * | 1986-04-14 | 1990-04-10 | The General Hospital Corporation | Fibrin-specific antibodies and method of screening for the antibodies |
EP0241907A3 (en) * | 1986-04-14 | 1989-09-13 | The General Hospital Corporation | Heterobifunctional antibodies and method of use |
WO1988001514A1 (en) * | 1986-08-25 | 1988-03-10 | American Biogenetic Sciences, Inc. | Monoclonal antibodies to fibrin |
DE3701812A1 (de) * | 1987-01-22 | 1988-08-04 | Max Planck Gesellschaft | Fibrinspezifischer antikoerper, verfahren zur seiner herstellung und seine verwendung |
US5120834A (en) * | 1988-06-13 | 1992-06-09 | American Biogenetic Sciences, Inc. | Fibrin-specific monoclonal antibody |
US5091512A (en) * | 1988-06-13 | 1992-02-25 | American Biogenetic Sciences, Inc. | Fibrinogen-specific monoclonal antibody |
ATE145007T1 (de) * | 1988-06-13 | 1996-11-15 | American Biogenetic Sciences | Verfahren zur herstellung monoklonaler antikörper mit hilfe eines keimfreien tieres |
US5223410A (en) * | 1988-06-13 | 1993-06-29 | American Biogenetic Sciences, Inc. | Method for production of antibodies utilizing an antigen-free animal |
US5206140A (en) | 1988-06-24 | 1993-04-27 | Research Corporation Technologies, Inc. | Assay for soluble crosslinked fibrin polymers |
CA2052283A1 (en) * | 1990-09-27 | 1992-03-28 | Edgar Haber | Recombinant hybrid immunoglobulin molecules and method of use |
-
1994
- 1994-02-24 US US08/204,015 patent/US5487892A/en not_active Expired - Lifetime
-
1995
- 1995-02-21 HU HU9602337A patent/HUT76536A/hu unknown
- 1995-02-21 NZ NZ281481A patent/NZ281481A/en unknown
- 1995-02-21 SG SG1996009046A patent/SG53279A1/en unknown
- 1995-02-21 KR KR1019960704600A patent/KR970701063A/ko not_active Application Discontinuation
- 1995-02-21 PL PL95316005A patent/PL316005A1/xx unknown
- 1995-02-21 UA UA96093639A patent/UA41984C2/uk unknown
- 1995-02-21 SK SK1084-96A patent/SK108496A3/sk unknown
- 1995-02-21 CA CA002183953A patent/CA2183953A1/en not_active Abandoned
- 1995-02-21 JP JP7522375A patent/JPH09509429A/ja not_active Ceased
- 1995-02-21 GE GEAP19953380A patent/GEP20002257B/en unknown
- 1995-02-21 BR BR9506949A patent/BR9506949A/pt not_active Application Discontinuation
- 1995-02-21 MX MX9603602A patent/MX9603602A/es unknown
- 1995-02-21 WO PCT/US1995/001825 patent/WO1995022986A1/en not_active Application Discontinuation
- 1995-02-21 MD MD96-0334A patent/MD1521G2/ro unknown
- 1995-02-21 TJ TJ96000411A patent/TJ301B/xx unknown
- 1995-02-21 CZ CZ962464A patent/CZ246496A3/cs unknown
- 1995-02-21 CN CN95192673A patent/CN1146157A/zh active Pending
- 1995-02-21 AU AU18434/95A patent/AU708897B2/en not_active Ceased
- 1995-02-21 EP EP95910251A patent/EP0749320A4/en not_active Withdrawn
- 1995-02-21 RU RU96119386/14A patent/RU2152801C2/ru active
-
1996
- 1996-08-22 NO NO963497A patent/NO963497L/no not_active Application Discontinuation
- 1996-08-23 FI FI963288A patent/FI963288A0/fi unknown
- 1996-09-23 LV LVP-96-379A patent/LV11784B/en unknown
- 1996-09-23 BG BG100863A patent/BG62476B1/bg unknown
- 1996-09-24 LT LT96-140A patent/LT4192B/lt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MD960334A (en) | 1997-09-30 |
EP0749320A1 (en) | 1996-12-27 |
LV11784A (lv) | 1997-06-20 |
AU1843495A (en) | 1995-09-11 |
BG100863A (en) | 1997-08-29 |
CN1146157A (zh) | 1997-03-26 |
CA2183953A1 (en) | 1995-08-31 |
UA41984C2 (uk) | 2001-10-15 |
LT96140A (en) | 1997-03-25 |
US5487892A (en) | 1996-01-30 |
PL316005A1 (en) | 1996-12-23 |
BR9506949A (pt) | 1997-09-23 |
BG62476B1 (bg) | 1999-12-30 |
HU9602337D0 (en) | 1996-10-28 |
NZ281481A (en) | 1998-07-28 |
KR970701063A (ko) | 1997-03-17 |
AU708897B2 (en) | 1999-08-12 |
GEP20002257B (en) | 2000-10-25 |
HUT76536A (en) | 1997-09-29 |
RU2152801C2 (ru) | 2000-07-20 |
FI963288A (fi) | 1996-08-23 |
CZ246496A3 (en) | 1997-04-16 |
FI963288A0 (fi) | 1996-08-23 |
SG53279A1 (en) | 1998-09-28 |
TJ301B (en) | 2001-08-06 |
LV11784B (en) | 1997-12-20 |
JPH09509429A (ja) | 1997-09-22 |
NO963497D0 (no) | 1996-08-22 |
WO1995022986A1 (en) | 1995-08-31 |
EP0749320A4 (en) | 1997-06-18 |
NO963497L (no) | 1996-10-16 |
MD1521G2 (ro) | 2001-03-31 |
SK108496A3 (en) | 1997-10-08 |
LT4192B (en) | 1997-07-25 |
MD1521F2 (en) | 2000-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0911039A3 (en) | Drug-resin complexes stabilized by chelating agents | |
MY118068A (en) | Protein kinase c inhibitor | |
MX9709240A (es) | Fenilpiridazinonas. | |
MY141384A (en) | Prevention of loss and restoration of bone mass by certain prostaglandin agonists | |
GR3035585T3 (en) | Polymer film compositions for capsules | |
PL306173A1 (en) | Novel inclusion complexes, method of obtaining them and pharmaceutical agent | |
BG105028A (en) | Bridged indenopyrrolocarbazoles | |
BG103310A (en) | Benzonaphthyridins as bronchial therapeutical means | |
HRP20020330A2 (en) | Novel oligosaccharides, preparation method and pharmaceutical compositions containing same | |
MX9603602A (es) | Anticuerpo especifico para fibrina para su uso como agente antitrombotico. | |
MX9804588A (es) | Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel. | |
HK1040983A1 (en) | Quinones for treatment of diseases. | |
BG102623A (en) | New derivatives of benzoylguanadine, methods for their preparation and application for the manufacture of medicamentous forms | |
DE69120287D1 (en) | Aminosulfonylharnstoff-acat-inhibitoren | |
MX9704034A (es) | Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso. | |
IL147123A0 (en) | Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies | |
EP0743861A4 (en) | RADIOACTIVELY MARKED ANNEXINS | |
BG103649A (en) | Method for the preparation of eprosartan | |
BG103650A (en) | Method for the preparation of eprosartan | |
AU2240597A (en) | Cardiovascular and thrombus imaging agents, methods and kits | |
ZA949564B (en) | Method for treating constipation using dimeticone. | |
BG102238A (en) | New imidazoline-2,4-dions of anticonvulsion effect containing, in the first place, orthosubstituted ar(alk)yl radical, and method for their preparation | |
WO2000036144A3 (en) | Cancer diagnostic method using p40 subunit of eif3 | |
UA42749C2 (uk) | N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування | |
AU5994696A (en) | Modified alpha-d-glcp-(1-2)-alpha-d-glcp-(1-3)-alpha-d-glcp- analogues |